Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

DreamHug Medical vs MyFastRx

DreamHug Medical
Graded #393

Lower grade

vs+9.800000000000004
MyFastRx
Graded #172

Higher grade

The verdict

MyFastRx takes it — 67.4/100 to 57.6/100.

MyFastRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MyFastRx is a cash-pay compounded-GLP-1 platform built around fast approval and discounted multi-month bundles.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMyFastRx +19
56
75
Dose & formulationMyFastRx +8
64
72
Clinical oversightMyFastRx +6
60
66
Labs & monitoringMyFastRx +2
50
52
FulfillmentMyFastRx +16
67
83
Contract termsEven
41
41
DreamHug Medical · left barMyFastRx · right bar

The numbers

MetricDreamHug MedicalMyFastRx
WeighScore57.6/10067.4/100
GradeCC
Scorecard rank#393#172
Semaglutide$188/mo (starting dose, compounded)$169/mo
Tirzepatide$238/mo (starting dose, compounded)$249/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
DreamHug Medical

Graded #393 · C

Strengths

  • Florida business address disclosed publicly (Pompano Beach, FL) — more transparency than many DTC competitors
  • 100% money-back guarantee if you're not approved
  • Telehealth-only with claimed all-50-state coverage via an 11,000-doctor network
  • LegitScript logo displayed

Where it loses points

  • Tirzepatide not mentioned — semaglutide-only, narrower scope than competitors
  • Pricing not disclosed — fully gated behind sign-up
  • LegitScript ID number not shown (only the logo)
  • Pharmacy partner not disclosed
  • Named medical director not disclosed
MyFastRx

Graded #172 · C

Strengths

  • Aggressive 12-month bundle pricing — $99/mo semaglutide, $149/mo tirzepatide
  • LegitScript certified
  • All doses priced the same — no cost escalation as you titrate up
  • First-month promo discount lowers the trial barrier

Where it loses points

  • States served not disclosed — only 'multiple states' / 'licensed U.S. providers'
  • Corporate address and medical director not published
  • Pharmacy partner not named — only 'state-licensed pharmacies'
  • Cash-pay only — no insurance billing
  • Bundle savings require a large upfront commitment (12 months billed at once)

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard